Astellas Pharma Inc (ALPMY)
9.39
-0.07
(-0.74%)
USD |
OTCM |
Apr 18, 10:14
Astellas Pharma Gross Profit Margin (Quarterly): 82.01% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.01% |
| September 30, 2023 | 81.02% |
| June 30, 2023 | 81.61% |
| March 31, 2023 | 82.42% |
| December 31, 2022 | 81.50% |
| September 30, 2022 | 83.50% |
| June 30, 2022 | 76.72% |
| March 31, 2022 | 80.61% |
| December 31, 2021 | 79.64% |
| September 30, 2021 | 80.80% |
| June 30, 2021 | 80.92% |
| March 31, 2021 | 81.10% |
| December 31, 2020 | 79.05% |
| September 30, 2020 | 80.59% |
| June 30, 2020 | 80.57% |
| March 31, 2020 | 82.36% |
| December 31, 2019 | 75.52% |
| September 30, 2019 | 78.39% |
| June 30, 2019 | 78.90% |
| March 31, 2019 | 78.65% |
| December 31, 2018 | 76.48% |
| September 30, 2018 | 77.11% |
| June 30, 2018 | 78.51% |
| March 31, 2018 | 81.61% |
| December 31, 2017 | 74.95% |
| Date | Value |
|---|---|
| September 30, 2017 | 78.07% |
| June 30, 2017 | 75.42% |
| March 31, 2017 | 77.22% |
| December 31, 2016 | 70.46% |
| September 30, 2016 | 76.19% |
| June 30, 2016 | 78.84% |
| March 31, 2016 | 78.80% |
| December 31, 2015 | 73.00% |
| September 30, 2015 | 77.22% |
| June 30, 2015 | 73.79% |
| March 31, 2015 | 74.97% |
| December 31, 2014 | 71.98% |
| September 30, 2014 | 72.23% |
| June 30, 2014 | 74.26% |
| March 31, 2014 | 74.25% |
| December 31, 2013 | 69.16% |
| September 30, 2013 | 71.04% |
| June 30, 2013 | 69.88% |
| March 31, 2013 | 72.19% |
| December 31, 2012 | 65.72% |
| September 30, 2012 | 67.12% |
| June 30, 2012 | 69.81% |
| March 31, 2012 | 62.50% |
| December 31, 2011 | 66.66% |
| September 30, 2011 | 69.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
75.52%
Minimum
Dec 2019
83.50%
Maximum
Sep 2022
80.38%
Average
80.80%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Daiichi Sankyo Co Ltd | 72.62% |
| Takeda Pharmaceutical Co Ltd | 65.85% |
| Nxera Pharma Co Ltd | 76.00% |
| PeptiDream Inc | 48.45% |
| Stemcell Holdings Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.18% |
| Return on Assets | -0.09% |
| Return on Invested Capital | -0.14% |
| Profit Margin (Quarterly) | 3.44% |
| Operating Margin (Quarterly) | 4.47% |
| Return on Net Operating Assets | -0.12% |